Global elimination of lymphatic filariasis: addressing the public health problem

Affiliations

Comment

David G Addiss. PLoS Negl Trop Dis. 2010.

. 2010 Jun 29;4(6):e741.

doi: 10.1371/journal.pntd.0000741.

¹ Fetzer Institute, Kalamazoo, Michigan, United States of America. daddiss@fetzer.org

No abstract available

Conflict of interest statement

The author has declared that no competing interests exist.

Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.
Cantey PT, Rout J, Rao G, Williamson J, Fox LM. Cantey PT, et al. PLoS Negl Trop Dis. 2010 Jun 29;4(6):e728. doi: 10.1371/journal.pntd.0000728. PLoS Negl Trop Dis. 2010. PMID: 20628595 Free PMC article.

1. Seim A, Dreyer G, Addiss D. Controlling morbidity and interrupting transmission: twin pillars of lymphatic filariasis elimination. Revista da Sociedade Brasileira de Medicina Tropical. 1999;32:325–328. - PubMed
1. Shenoy RK, Sandhya K, Suma TK, Kumaraswami V. A preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities. Southeast Asian J Trop Med Public Health. 1995;26:301–305. - PubMed
1. Dreyer G, Medeiros Z, Netto MJ, Leal NC, de Castro LG, et al. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans R Soc Trop Med Hyg. 1999;93:413–417. - PubMed
1. Addiss DG, Brady MA. 2007. Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: A review of the scientific literature. Filaria J 6:2. Available: http://www.filariajournal.com/content/6/1/2. - PMC - PubMed
1. World Health Organization. Global programme to eliminate lymphatic filariasis. Wkly Epidemiol Rec. 2009;84:437–444. - PubMed